Draper Therapies Happy to Announce U.S. FDA Determines Celliant® Responsive Textile Products Meet Criteria as Medical Devices and General Wellness Products

July 27, 2017, Canton, MA – Draper Therapies is thrilled to announce that the United States Food and Drug Administration has determined that products containing Celliant® meet the criteria for medical devices and general wellness products and will be categorized as such. All of Draper Therapies’ products contain Celliant, a smart fiber clinically proven to:

Temporarily increases local circulation
Increases cellular oxygenation
Increases tissue oxygen levels
Enhances/increases performance
Increases/more energy
Increases/more/better endurance
Increases/enhances/more speed
Improves/increases strength
Increases/more stamina
Faster/quicker recovery
Promotes restful sleep
Helps increase comfort
Recycles human energy

After eleven years of producing and working with Celliant fabrics, Kristin Draper, president of Draper Therapies isn’t surprised. “When I was first introduced to Celliant® I was a skeptic too,” says Kristin, “but after seeing the remarkable way it increased comfort for both myself and my family, we knew this was a winner. We have been working with Seth (of Hologenix LLC, the company responsible for inventing Celliant) since the beginning and made fabrics, then equestrian products, which lead to dog and human products. It continues to amaze me – the very human testimonials about how products made with Celliant are making lives better.”

Celliant products will be regulated as both medical devices as defined in section 201(h) of the Federal Food, Drug and Cosmetic Act (“Act”), and are also as “general wellness products.” The FDA has defined a general wellness product as one that has (1) an intended use that relates to maintaining or encouraging a general state of health or a healthy activity, or (2) an intended use that relates the role of a healthy lifestyle with helping to reduce the risk or impact of certain chronic diseases or conditions and where it is well understood and accepted that healthy lifestyle choices may play an important role in health outcomes for the disease or condition.

“I think this is incredibly important because it will encourage folks to try our products and generate interest in responsive textiles in general.” says Draper Therapies product manager Becky Shipps. “I am excited for the future of both Draper Therapies and Celliant!”

To shop the Draper Therapies product line, click here.

To read more about Celliant, click here.

To read the full press release from PR News Wire, click here.

Draper Therapies Happy to Announce U.S. FDA Determines Celliant® Responsive Textile Products Meet Criteria as Medical Devices and General Wellness Products